Risks and benefits of hormone replacement therapy

July 1997

An important study in the latest NEJM sheds new light on the risks and benefits of hormone replacement therapy.

Estrogen use reduces mortality by about 40%...primarily by decreasing death from heart disease.

But the study shows this benefit declines after 10 years...because of an increase in mortality from breast cancer.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote